RecruitingNCT05736198

Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation


Sponsor

University of Illinois at Chicago

Enrollment

96 participants

Start Date

Aug 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and fentanyl are approved by the Food and Drug Administration (FDA) procedural sedation. These drugs might be given to the patient regardless of their participation in the study. In addition to midazolam and fentanyl study subjects will also receive either dexmedetomidine or a placebo (a salt solution that contains no drug). It is believed that dexmedetomidine will not slow down breathing as much as the combination of the valium-like drug and narcotic. In our study, we are trying to determine if this is the best drug for sedation during an awake fiberoptic procedure.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Subjects with potentially difficult airways who require awake fiberoptic intubations will be identified from the OR schedule and the pre-operative clinic workups.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

dexmedetomidine, midazolam, and fentanyl (titrated to effect) to facilitate intubation


Locations(1)

University of Illinois

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05736198


Related Trials